Evaluation of PDE4 inhibition for COPD-Reference-Cited by-同舟云学术

Evaluation of PDE4 inhibition for COPD

Published:2006-12 Issue:4 Volume:1 Page:373-379
ISSN:1176-9106
Container-title:International Journal of COPD
language:en
Short-container-title:International Journal of COPD

Author:

Wang Desuo,Cui Xiangli

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pulmonary and Respiratory Medicine,General Medicine

Reference58 articles.

1. Sildenafil improves hemodynamic parameters in COPD—an investigation of six patients

2. Altana. 2005a. ALTANA has withdrawn the EU marketing authorisation application for Daxas. [online]. Accessed 16 June 2006. URL: http:/ /www.altana.com/files/pressemeldungen/altana_pm_2005-11-15_b2771aa087.pdf

3. Altana. 2005b. Top line results of first one-year COPD study with Daxas [online]. Accessed 16 June 2006. URL:http://www.altana.com/ files/pressemeldungen/altana_pm_2005-07-01_d26089802f.pdf

4. Phorbol 12-myristate 13-acetate Triggers the Protein Kinase A-Mediated Phosphorylation and Activation of the PDE4D5 cAMP Phosphodiesterase in Human Aortic Smooth Muscle Cells through a Route Involving Extracellular Signal Regulated Kinase (ERK)

5. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sappanone A: A natural PDE4 inhibitor with dual anti-inflammatory and antioxidant activities from the heartwood of Caesalpinia sappan L.;Journal of Ethnopharmacology;2023-03

2. Exploring the Activity Profile of TbrPDEB1 and hPDE4 Inhibitors Using Free Energy Perturbation;ACS Medicinal Chemistry Letters;2022-05-23

3. PI3K signalling in chronic obstructive pulmonary disease and opportunities for therapy;The Journal of Pathology;2021-05-07

4. Current and Emerging Therapies in Chronic Obstructive Pulmonary Disease;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

5. Exploring the Role of Water Molecules in the Ligand Binding Domain of PDE4B and PDE4D: Virtual Screening Based Molecular Docking of Some Active Scaffolds;Current Computer-Aided Drug Design;2019-07-01